BNP Paribas Asset Management
HZNP

BNP Paribas Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

BNP Paribas Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,129
Closed -$1.17M – 874
2023
Q3 		$1.17M Sell
10,129
-799
-7% -$85.8K ﹤0.01% 717
2023
Q2 		$1.12M Buy
10,928
+717
+7% +$75.6K ﹤0.01% 717
2023
Q1 		$1.11M Sell
10,211
-673,689
-99% -$74.5M ﹤0.01% 743
2022
Q4 		$77.8M Sell
683,900
-384,413
-36% -$31.9M 0.28% 90
2022
Q3 		$66.1M Buy
1,068,313
+358,243
+50% +$25M 0.26% 87
2022
Q2 		$56.6M Buy
710,070
+116,024
+20% +$11M 0.22% 117
2022
Q1 		$62.5M Buy
594,046
+36,155
+6% +$3.52M 0.22% 106
2021
Q4 		$60.1M Buy
557,891
+212,466
+62% +$23.2M 0.2% 118
2021
Q3 		$37.8M Buy
345,425
+20,452
+6% +$2.12M 0.14% 183
2021
Q2 		$30.4M Buy
324,973
+194,646
+149% +$17.9M 0.11% 234
2021
Q1 		$12M Buy
130,327
+126,530
+3,332% +$10.7M 0.05% 377
2020
Q4 		$278K Buy
+3,797
New +$282K ﹤0.01% 811

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BNP Paribas Asset Management's HZNP Position: Q4 2023 in Review

BNP Paribas Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 10,129 shares — an estimated $1.17M sold.

BNP Paribas Asset Management first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $77.8M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • BNP Paribas Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • BNP Paribas Asset Management sold 10,129 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.17M.
  • BNP Paribas Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • BNP Paribas Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $77.8M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on BNP Paribas Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.